We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Endotoxemia Genetic Profile Reveals an Association with Thromboembolism and Stroke

By LabMedica International staff writers
Posted on 09 Nov 2021
Print article
Image: The limulus amebocyte lysate (LAL) assay measures endotoxin activity (Photo courtesy of HyCult Biotechnology)
Image: The limulus amebocyte lysate (LAL) assay measures endotoxin activity (Photo courtesy of HyCult Biotechnology)
Microorganisms are part of the human body, and bacteria or their components often end up in the circulation. One such bacterial component is lipopolysaccharide (LPS), which is a toxin. High concentrations of LPS in the blood cause sepsis. Low LPS levels, known as endotoxemia, cause low-grade inflammation.

Translocation of LPS in the circulation, endotoxemia, can occur in the interface of host mucosal microbiota and the bloodstream (e.g., in the gut). Endotoxemia is associated with an increased risk of cardiometabolic disorders, including incident cardiovascular disease events, obesity, metabolic syndrome, and diabetes.

A team of medical scientists at the Helsinki University Hospital (Helsinki, Finland) performed a genome‐wide association study of serum lipopolysaccharide activity in 11,296 individuals from six different Finnish study cohorts. Endotoxin activities were determined with a limulus amebocyte lysate (LAL) assay on 1:5 diluted serum samples (HyCult Biotechnology b.v., Uden, the Netherlands), and the results were log transformed (natural logarithm) because of skewed distributions.

A subpopulation of 363 subjects was used to determine endotoxemia by mass spectrometry–based method and a commercially available Endolisa assay (Hyglos GmbH, Bernried, Germany) on 326 individuals. Cohorts were genotyped with various genotyping platforms and went through rigorous quality control. Imputation was performed using 1000 Genomes Project phase 3 reference genotypes.

The investigators reported that lipopolysaccharide activity had a genome‐wide significant association with 741 single‐nucleotide polymorphisms in five independent loci, which were mainly located at genes affecting the contact activation of the coagulation cascade and lipoprotein metabolism and explained 1.5% to 9.2% of the variability in lipopolysaccharide activity levels. The closest genes included KNG1, KLKB1, F12, SLC34A1, YPEL4, CLP1, ZDHHC5, SERPING1, CBX5, and LIPC. The genetic risk score of endotoxemia was associated with deep vein thrombosis, pulmonary embolism, pulmonary heart disease, and venous thromboembolism.

Jaakko Leskelä, DDS, the first author of the study, said, “As an entirely new find, we identified an apparent link between the human genome and the amount of bacterial toxins in the blood. Our findings connected endotoxemia particularly with blood clots, strokes and other diseases related to blood coagulation.”

The authors concluded that the biological activity of lipopolysaccharide in the circulation (i.e., endotoxemia) has a small but highly significant genetic component. Endotoxemia is associated with genetic variation in the contact activation pathway, vasoactivity, and lipoprotein metabolism, which play important roles in host defense, lipopolysaccharide neutralization, and thrombosis, and thereby thromboembolism and stroke. The study was published on October 20, 2021 in the Journal of the American Heart Association.

Related Links:
Helsinki University Hospital
HyCult Biotechnology
Hyglos GmbH

Gold Supplier
Pipette Tips
Sapphire Pipette Tips
New
Silver Supplier
Bacteriuria Test Strips
MAST Bacteruritest Strips
New
Vented Safety Enclosures
VSE Balance Enclosures
New
Silver Supplier
COVID-19 Ag Self Test
OnSite COVID-19 Ag Self Test

Print article

Channels

Hematology

view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more

Immunology

view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more

Microbiology

view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more

Pathology

view channel
Illustration

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more

Industry

view channel
Illustration

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.